Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3991 AL 4005

The Exceptional Vulnerability of Humans to Alzheimer's Disease

Walker LC, Jucker M.

Trends Mol Med. 2017 Jun;23(6):534-545. doi: 10.1016/j.molmed.2017.04.001. Epub 2017 May 5.

Emerging amyloid and tau targeting treatments for Alzheimer's disease

Khan A, Corbett A, Ballard C.

Expert Rev Neurother. 2017 Jul;17(7):697-711. doi: 10.1080/14737175.2017.1326819. Epub 2017 May 19.

Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets

Khan A, Corbett A, Ballard C.

Expert Rev Neurother. 2017 Jul;17(7):683-695. doi: 10.1080/14737175.2017.1326818. Epub 2017 May 18.

Alzheimer's disease, dementia, and stem cell therapy

Duncan T, Valenzuela M.

Stem Cell Res Ther. 2017 May 12;8(1):111. doi: 10.1186/s13287-017-0567-5.

Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease

Knez D, Sova M, Košak U, Gobec S.

Future Med Chem. 2017 May;9(8):811-832. doi: 10.4155/fmc-2017-0036. Epub 2017 May 15.

Modulating 5-HT(4) and 5-HT(6) receptors in Alzheimer's disease treatment

Lalut J, Karila D, Dallemagne P, Rochais C.

Future Med Chem. 2017 May;9(8):781-795. doi: 10.4155/fmc-2017-0031. Epub 2017 May 15.

Multi-omics and Alzheimer's disease: a slower but surer path to an efficacious therapy?

Pimplikar SW.

Am J Physiol Cell Physiol. 2017 Jul 1;313(1):C1-C2. doi: 10.1152/ajpcell.00109.2017. Epub 2017 May 17.

The Mechanisms of Action of Curcumin in Alzheimer's Disease

Tang M, Taghibiglou C.

J Alzheimers Dis. 2017;58(4):1003-1016. doi: 10.3233/JAD-170188.

Pharmacological treatment of Alzheimer's disease in the population of Catalonia, Spain

Obach M, Lopez P, Catalan A.

Med Clin (Barc). 2017 Jul 21;149(2):86-87. doi: 10.1016/j.medcli.2017.03.030. Epub 2017 May 17.

Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease

Kwon Y.

Exp Gerontol. 2017 Sep;95:39-43. doi: 10.1016/j.exger.2017.05.014. Epub 2017 May 17.

Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b

Huang W, Li Z, Zhao L, Zhao W.

Biomed Pharmacother. 2017 Aug;92:46-57. doi: 10.1016/j.biopha.2017.05.060. Epub 2017 May 18.

Multi-functional activities of citrus flavonoid narirutin in Alzheimer's disease therapeutics: An integrated screening approach and in vitro validation

Chakraborty S, Basu S.

Int J Biol Macromol. 2017 Oct;103:733-743. doi: 10.1016/j.ijbiomac.2017.05.110. Epub 2017 May 19.

Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease

Qiu WQ.

Neuroscience. 2017 Jul 25;356:44-51. doi: 10.1016/j.neuroscience.2017.05.024. Epub 2017 May 19.

[Evaluation of the animal-assisted therapy in Alzheimer's disease]

Quibel C, Bonin M, Bonnet M, Gaimard M, Mourey F, Moesch I, Ancet P.

Soins Gerontol. 2017 May-Jun;22(125):35-38. doi: 10.1016/j.sger.2017.03.008.

[Anti-ageing therapies in Alzheimer's disease]

Alonso Abreu GS, Brito Armas JM, Castro Fuentes R.

Rev Esp Geriatr Gerontol. 2018 Jan-Feb;53(1):45-53. doi: 10.1016/j.regg.2017.02.007. Epub 2017 May 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias